PATENT CLAIM ANALYSIS

Application Number: 15884428
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-06
Patent Classification: ["424", "186100"]

Abstract:
A method of treating a subject having or at risk for having a virus infection, by administering to the subject a therapeutically effective amount of a composition comprising a vector encoding a CRISPR-associated endonuclease and at least two guide RNAs, wherein the guide RNAs are complementary to two target sequences spanning from the 5′- to 3′-LTRs of the sequence in the virus, and completely resolving the symptoms of a disease, decreasing the severity of the symptoms of the disease, or slowing the disease's progression.

Claim (Index 15):
The method of  claim 1 , wherein the symptoms are chosen from the group consisting of fever, headache, muscle aches, rash, chills, sore throat, mouth or genital ulcers, swollen lymph glands, joint pain, night sweats, and diarrhea.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 86.0
- Lexical Diversity: 1.71698
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14838057', '15148261', '14644181', '15127087', '15449181']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7839687262564032
- 35 USC 102 Novelty (BERT): 0.5686342105731271
- Combined Prediction Score: 0.7624352746880756
- Mean Citation Score: 406.35744
- Max Citation Score: 571.3226
- Similarity Product: 335.40917850826975

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test